Medical Sales, Device Sales & MedTech News — 2026-08-04

Here is a short roundup of recent medical sales, medical device sales, medtech, pharma, and biotech headlines — useful context for reps, RSDs, and hiring teams watching the market.

Headlines worth watching

• DMG MORI targets production turning for medtech industry (Today's Medical Developments): The company's integrated manufacturing solutions address key requirements of medical device manufacturing such as high precision, reproducible quality,...
• What J&J’s Ottava robot brings to the surgical table (MedTech Dive): Rocco De Bernardis, global president for Ottava, gets into the details of what makes the new robotic surgery system different from the competition and how...
• GE HealthCare Posts Best Orders Quarter Since 2023 Spinoff, But Payoff Is Deferred To 2027 (Medtech Insight): GE HealthCare posted its strongest orders quarter since its 2023 spinoff, with an 11.1% organic rise and a $23.9bn backlog, and flagged that much of the...
• Medtech’s agentic AI moment: Turning ambition into enterprise advantage (Deloitte): Medtech leaders can turn agentic AI ambition into enterprise advantage by redesigning workflows, governance, and data.
• MiMedx to acquire Sanara MedTech for $350M (MassDevice): MiMedx Group will acquire Sanara MedTech in a cash-and-stock transaction valued at $35 per Sanara share.

Source links

What this means for medical sales careers

Product launches, clearances, and commercial expansion often show up first as hiring demand for territory managers, clinical specialists, and specialty sales roles. Use the headlines above as conversation starters — then verify openings and fit before you apply or post a role.